Results 171 to 180 of about 1,388,983 (287)
Advances in the Development of Lipid Nanoparticles for mRNA Delivery
Small Structures, Volume 7, Issue 2, February 2026.This review provides an integrated overview of mRNA–lipid nanoparticle (LNP) design, including lipid composition, scalable manufacturing, and structure–activity relationships. We highlight strategies for targeted delivery, physicochemical tuning, and high‐throughput screening such as DNA barcoding.
Xing Wang +6 more
wiley +1 more source
Malaga Moderna: the role of planning and morphological change in changing the image of the city, 1880-1936 [PDF]
, 2011 Barke, Mike
core
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1105-1115, February 2026.Abstract Background Albuminuria is associated with an increased risk of cardiovascular and kidney events. Sodium glucose co‐transporter 2 inhibitors (SGLT2i) reduce albuminuria and improve kidney outcomes in patients with albuminuric chronic kidney disease (CKD).
João Pedro Ferreira +10 more
wiley +1 more source
Mills and society in early medieval northern Italy
Early Medieval Europe, Volume 34, Issue 1, Page 3-33, February 2026.Drawing on the extensive documentary record of northern Italy, available archaeological evidence, and comparative case studies from early medieval Europe, this study demonstrates that mill‐based landscapes in the Po and Friuli‐Venetian plains were shaped by society as a whole.
Marco Panato
wiley +1 more source
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis
European Journal of Neurology, Volume 33, Issue 2, February 2026.This was a national multicenter comparative effectiveness research study using data from the Danish Multiple Sclerosis Registry. Relapsing–remitting multiple sclerosis patients initiating ocrelizumab or natalizumab between January 2018 to April 2023 were included.
Camilla Maersk‐Moller +18 more
wiley +1 more source
Influenza and Other Respiratory Viruses, Volume 20, Issue 2, February 2026.ABSTRACT Background Male sex is a well‐known risk factor for respiratory syncytial virus (RSV) hospitalization in children, but there are no data on potential differences in clinical features between boys and girls hospitalized with RSV infection. Methods We compared the average population‐based rates of hospitalization and the clinical features of the
Erika Uusitupa +3 more
wiley +1 more source